Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
the enzyme which catalyzes the conversion of HMG-CoA to mevalonate
Solubility: DMSO : 100 mg/mL (246
(2000)68 79
Drospirenone binds to the progesterone receptor
Betrixaban 40551 the enzyme which catalyzes theBetrixaban, also known as PRT054021, MK 4448; PRT 021; PRT 054021; MLN 1021, is a potent, orally active and highly selective factor Xa inhibitor undergone human clinical trials for prevention of embolism after knee surgery, and prevention of stroke following atrial fibrillation. Betrixaban is currently being studied in a human clinical trial for extended duration thromboprophylaxis to prevent venous thromboembolism in acute medically ill patients.